Literature DB >> 31021186

Genome Editing B.C. (Before CRISPR): Lasting Lessons from the "Old Testament".

Fyodor D Urnov1.   

Abstract

Genome editing with engineered nucleases, a powerful tool for understanding biological function and revealing causality, was built in a joint effort by academia and industry in 1994-2010. Use of CRISPR-Cas9 is the most recent (2013-), and facile, implementation of the resulting editing toolbox. Principles and methods of genome editing from the pre-CRISPR era remain relevant and continue to be useful.

Year:  2018        PMID： 31021186     DOI： 10.1089/crispr.2018.29007.fyu

Source DB:  PubMed          Journal:  CRISPR J        ISSN： 2573-1599


  12 in total

1.  Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.

Authors:  Rafet Basar; May Daher; Nadima Uprety; Elif Gokdemir; Abdullah Alsuliman; Emily Ensley; Gonca Ozcan; Mayela Mendt; Mayra Hernandez Sanabria; Lucila Nassif Kerbauy; Ana Karen Nunez Cortes; Li Li; Pinaki P Banerjee; Luis Muniz-Feliciano; Sunil Acharya; Natalie W Fowlkes; Junjun Lu; Sufang Li; Stephan Mielke; Mecit Kaplan; Vandana Nandivada; Mustafa Bdaiwi; Alexander D Kontoyiannis; Ye Li; Enli Liu; Sonny Ang; David Marin; Lorenzo Brunetti; Michael C Gundry; Rolf Turk; Mollie S Schubert; Garrett R Rettig; Matthew S McNeill; Gavin Kurgan; Mark A Behlke; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2020-07-28

2.  Hijack of CRISPR defences by selfish genes holds clinical promise.

Authors:  Fyodor D Urnov
Journal:  Nature       Date:  2019-07       Impact factor: 49.962

Review 3.  The Landscape of Early Clinical Gene Therapies outside of Oncology.

Authors:  Laure Rittié; Takis Athanasopoulos; Miguel Calero-Garcia; Marie L Davies; David J Dow; Steven J Howe; Alastair Morrison; Ida Ricciardelli; Aurore Saudemont; Laurent Jespers; Timothy M Clay
Journal:  Mol Ther       Date:  2019-09-06       Impact factor: 11.454

4.  Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling.

Authors:  Ivan E Ivanov; Addison V Wright; Joshua C Cofsky; Kevin D Palacio Aris; Jennifer A Doudna; Zev Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

Review 5.  Therapeutic in vivo delivery of gene editing agents.

Authors:  Aditya Raguram; Samagya Banskota; David R Liu
Journal:  Cell       Date:  2022-07-06       Impact factor: 66.850

Review 6.  CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.

Authors:  Dan Wang; Feng Zhang; Guangping Gao
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

7.  Tetrazine-Ligated CRISPR sgRNAs for Efficient Genome Editing.

Authors:  Zexiang Chen; Gitali Devi; Amena Arif; Phillip D Zamore; Erik J Sontheimer; Jonathan K Watts
Journal:  ACS Chem Biol       Date:  2022-04-21       Impact factor: 4.634

Review 8.  Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis-Learning from Other Diseases.

Authors:  Karen Mention; Lúcia Santos; Patrick T Harrison
Journal:  Genes (Basel)       Date:  2019-05-21       Impact factor: 4.096

9.  Chromosome Transplantation: A Possible Approach to Treat Human X-linked Disorders.

Authors:  Marianna Paulis; Lucia Susani; Alessandra Castelli; Teruhiko Suzuki; Takahiko Hara; Letizia Straniero; Stefano Duga; Dario Strina; Stefano Mantero; Elena Caldana; Lucia Sergi Sergi; Anna Villa; Paolo Vezzoni
Journal:  Mol Ther Methods Clin Dev       Date:  2020-01-21       Impact factor: 6.698

10.  Dynamic Genome Editing Using In Vivo Synthesized Donor ssDNA in Escherichia coli.

Authors:  Min Hao; Zhaoguan Wang; Hongyan Qiao; Peng Yin; Jianjun Qiao; Hao Qi
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.